"We have neurology, palliative care and oncology teams located within The University of Kansas Clinical Research Center in Fairway, Kansas. Clinical care and research is carried out in a collaborative environment, leading to breakthroughs in oncology care, Alzheimer's care and more."

During the past decade, University of Kansas Clinical Research Center conducted 152 clinical trials. In the 10-year time frame, 152 clinical trials started and 24 clinical trials were completed, i.e. on average, 15.8% percent of trials that started reached the finish line to date. In the past 5 years, 78 clinical trials started and 20 clinical trials were completed. i.e. 25.6% of trials that started reached the finish line.

Out of the total clinical trials conducted in "University of Kansas Clinical Research Center" #1 sponsor was "National Cancer Institute (NCI)" with 50 trials, followed by "University of Kansas Medical Center" with 10 trials sponsored, "Pfizer" with 9 trials sponsored, "Eli Lilly and Company" with 7 trials sponsored and "Celgene" with 7 trials sponsored. Other sponsors include 80 different institutions and companies that sponsored additional 73 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "University of Kansas Clinical Research Center" #1 collaborator was "National Cancer Institute (NCI)" with 9 trials as a collaborator, "Alzheimer's Therapeutic Research Institute" with 4 trials as a collaborator, "National Institute on Aging (NIA)" with 4 trials as a collaborator, "Alzheimer's Association" with 3 trials as a collaborator and "Bristol-Myers Squibb" with 3 trials as a collaborator. Other collaborators include 49 different institutions and companies that were collaborators in the rest 50 trials.

According to Clinical.Site data, the most researched conditions in "University of Kansas Clinical Research Center" are "Acute Myeloid Leukemia" (10 trials), "Multiple Myeloma" (7 trials), "Alzheimer Disease" (6 trials), "Advanced Solid Tumors" (5 trials) and "Metastatic Malignant Solid Neoplasm" (5 trials). Many other conditions were trialed in "University of Kansas Clinical Research Center" in a lesser frequency.

Most popular intervention types in "University of Kansas Clinical Research Center" are "Drug" (136 trials), "Biological" (43 trials), "Other" (35 trials), "Procedure" (27 trials) and "Radiation" (10 trials). Other intervention types were less common.

The name of intervention was led by "Biospecimen Collection" (21 trials), "Computed Tomography" (20 trials), "Laboratory Biomarker Analysis" (17 trials), "Nivolumab" (17 trials) and "Placebo" (17 trials). Other intervention names were less common.

The vast majority of trials in "University of Kansas Clinical Research Center" are 144 trials for "All" genders, 12 trials for "Male" genders and 9 trials for "Female" genders.

Currently, there are NaN active trials in "University of Kansas Clinical Research Center". undefined are not yet recruiting, 59 are recruiting, 61 are Active, not recruiting, and 1 are Enrolling by invitation. In total, there were 31 completed trials in University of Kansas Clinical Research Center, 1 suspended trials, and 9 terminated clinical trials to date.

Out of the total trials that were conducted in University of Kansas Clinical Research Center, 60 "Phase 1" clinical trials were conducted, 88 "Phase 2" clinical trials and 31 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 3 trials that are defined as “Not Applicable".